[Not Available].

Review approach involved evaluating two distinct labeling strategies to monitor protein movement across dermal barriers. The researchers first attempted biosynthetic incorporation of carbon-14 into proline residues within the peptide chain. They subsequently shifted to a chemical approach involving the incorporation of iodine-125 into tyrosine residues. This second technique relied on the oxidation of tagged iodide in the presence of the protein. The team performed purification using chromatography and successive dialyses to isolate the labeled material. They applied the final product to animal skin using either a sorbic acid solution or a cosmetic cream. The investigators tracked penetration by measuring radioactivity in tissue sections at specific time intervals. They also conducted metabolic studies to determine the long-term distribution and excretion of the tracer.

The strongest finding indicates that cream formulations significantly enhance protein penetration compared to simple aqueous solutions. Maximum absorption occurred within 15 minutes of application for both tested vehicles. Metabolic analysis revealed that 15 days post-application, residual radioactivity resided primarily in the lymphatic glands and skin. Treated areas consistently displayed higher activity levels than untreated control sites. Excretion of the radioactive tracer dropped to very low levels by the tenth day. Chromatography on molecular sieves confirmed that the majority of the detected signal originated from intact peptide chains. No radioactivity was detected in the interior of the deeper tissue layers at the measured time points. These results suggest that the chemical labeling process successfully maintained the active principles of the protein.

The authors propose that iodine-125 labeling provides a robust mechanism for monitoring protein penetration in skin tissues. Synthesis and implications suggest that cream formulations facilitate superior absorption compared to aqueous solutions. The researchers note that the majority of the labeled material remains localized within the skin and lymphatic glands. Their findings indicate that the protein maintains its structural integrity during the absorption process. The authors suggest that excretion rates decline significantly within ten days of initial application. Their data demonstrate that the largest portion of the detected signal originates from intact peptide chains. The researchers conclude that this radio-tracer technique offers a viable pathway for evaluating topical delivery systems. Their work implies that chemical modification via tyrosine oxidation does not interfere with the active principles of the protein.